Skip to main content

Month: March 2020

Eik fasteignafélag hf.: Breytt afkomuspá 2020, frestun aðalfundar og lok endurkaupaáætlunar

Eik fasteignafélag hf. („Eik“ eða „félagið“) hefur vegna áhrifa COVID-19 ákveðið að:fella úr gildi afkomuspá félagsins fyrir árið 2020,fresta aðalfundi hluthafa sem fram átti að fara 2. apríl 2020, ogljúka endurkaupaáætlun félagsins sem tilkynnt var um 10. mars 2020.Breytingar á afkomuspá fyrir árið 2020Eik birti afkomuspá fyrir árið 2020 þann 13. febrúar sl. Forsendur spárinnar breytast dag frá degi vegna mikillar óvissu um áhrif COVID-19 á íslenskt efnahagslíf og er það mat félagsins að forsendur spárinnar séu brostnar.Árið fór vel af stað og var rekstur félagsins fyrstu tvo mánuði ársins lítillega yfir áætlunum. Útlit er fyrir að mars verði nokkuð undir væntingum enda hafa tekjur Hótel 1919 dregist mikið saman. Leitast hefur verið við að draga úr kostnaði hótelsins og kann því að verða lokað tímabundið. Rekstrarkostnaður hótelsins...

Continue reading

Philips successfully prices offering of Notes for EUR 1 billion

March 25, 2020Amsterdam, the Netherlands – Koninklijke Philips N.V. (“Royal Philips”) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its issue of EUR 500 million fixed rate notes due 2025 and EUR 500 million fixed rate notes due 2030 (together the “Notes”).The net proceeds of the offering are intended for general company purposes and sustainable innovation expenditures as defined in the ESG framework available on the debt section of Philips Investor Relations website, and will further enhance the company’s liquidity position in view of the possible continued impact of the COVID-19 pandemic on financial markets in 2020.The issue price for the notes due 2025 is 99.550% with a Coupon of 1.375%, resulting in a yield of 1.469%. The issue price for the notes due 2030 is 99.204% with a...

Continue reading

TrackX Completes Sale of Yard Management Business to FourKites®

Key highlights:The sale of Yard Management will strengthen TrackX balance sheet Creates joint sales and marketing opportunities through FourKites expansive networkEnables TrackX to focus on high margin, repeatable SaaS-based asset management solutionsFurther differentiates FourKites as the leader in supply chain visibility and execution solutionsDENVER, March 25, 2020 (GLOBE NEWSWIRE) — TrackX Holdings Inc. (TSX.V:TKX | OTC: TKXHF | FRANKFURT:3TH) (“TrackX” or the “Company”), a SaaS-based enterprise asset management solution provider, announces it has completed a strategic transaction with FourKites, the Chicago-based creator of the predictive supply chain visibility category, in which FourKites has acquired the TrackX Yard Management business, related intellectual property and customer Yard contracts.The TransactionUnder the terms...

Continue reading

Aéroports de Paris SA: Information concerning the credit rating regarding Aéroports de Paris

FINANCIAL RELEASE25 March 2020Aéroports de Paris SAInformation concerning the long term credit rating regardingAéroports de ParisAéroports de Paris takes note of today’s decision by the rating agency Standard and Poor’s to revise the long term credit rating of the company, due to the traffic decrease linked to the Covid-19 epidemic. This rating is now A, with a negative outlook, while it has been A+ with a negative outlook since 27 February 2020.The agency highlights in particular that: “The airports sector in Europe is facing an unprecedented decline in air traffic as Europe has become the epicenter of the COVID-19 pandemic”. Regarding ADP, it precises that: “Liquidity remains adequate, despite our expectations of lower cash flow generation over the next 12 months. One of the company’s credit strengths...

Continue reading

Aéroports de Paris SA : Information concernant la notation relative à Aéroports de Paris

COMMUNIQUE FINANCIERTremblay-en-France, le 25 mars 2020Aéroports de Paris SAInformation concernant la notation de crédit long terme relative à Aéroports de ParisAéroports de Paris prend acte de la décision de ce jour de l’agence de notation Standard and Poor’s de réviser la notation de crédit long terme de l’entreprise en raison de la baisse du trafic en lien avec l’épidémie de Covid-19. Cette notation est désormais A, avec une perspective négative tandis qu’elle était A+ avec une perspective négative depuis le 27 février 2020.L’agence souligne notamment que : “The airports sector in Europe is facing an unprecedented decline in air traffic as Europe has become the epicenter of the COVID-19 pandemic.” S’agissant d’ADP, elle précise que : ” Liquidity remains adequate, despite...

Continue reading

Eurobio Scientific gets CE marking for its proprietary COVID-19 test

Eurobio Scientific gets CE marking for its proprietary COVID-19 testParis, March 25, 2020 – 5:45pmEurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in the field of specialty in vitro medical diagnostics, is today announcing the CE marking for its EBX 041 SARS CoV2 proprietary test, developed specifically for the clinical diagnosis of COVID-19.The EBX 041 SARS CoV2 proprietary kit follows the design recommended by the French National Reference Center (CNR) and has been approved based on clinical samples with an independent hospital. This is a multiplex kit with three targets: two for identifying the virus and one target for a control integrated into each patient test.The test is being produced in-house by Eurobio, at its recently renovated Les Ulis facility, following the regulatory standard process...

Continue reading

Eurobio Scientific obtient le marquage CE pour son test COVID-19 propriétaire

Eurobio Scientific obtient le marquage CE pour son test COVID-19 propriétaireParis, le 25 mars 2020 –17h45Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, annonce ce jour le marquage CE pour son test propriétaire EBX 041 SARS CoV2, développé spécifiquement pour le diagnostic clinique duCOVID-19.Le kit propriétaire EBX 041 SARS CoV2 suit le design recommandé par le Centre National de Référence et a été validé sur échantillons cliniques avec un hôpital indépendant. Il s’agit d’un kit multiplex avec 3 cibles, 2 pour l’identification du virus et une cible pour un contrôle intégré à chaque test patient.Le test est produit en interne par Eurobio, dans ses locaux des Ulis récemment rénovés et suit le processus normatif règlementaire ISO 13481. La capacité de...

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 25 March 2020

Rovio Entertainment Corporation – Repurchase of own shares on 25 March 2020Rovio Entertainment Corporation                 STOCK EXCHANGE RELEASE                   25 March 2020 AT 18:45 EETIn the Nasdaq HelsinkiDate                                                                                25 March 2020Exchange transaction                                                       BuyShare trading code                                                           ROVIOAmount, shares                                                                52252Average price/share, EUR                                                 4,105444Total cost, EUR                                                                214517,66ROVIO now holds a total of 4 054 058 own shares (ROVIO) including the shares repurchased on 25 March 2020.On behalf of Rovio...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.